Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 30, 2019
Mustang Bio Announces Pricing of Public Offering of Common Stock
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell ...
April 29, 2019
Santhera Reports Strong Top-line Growth for 2018 and the Successful Expansion of its Rare Disease Pipeline
Pratteln, Switzerland, April 29, 2019 - Santhera Pharmaceuticals (SANN.SW) announces the Group`s audited financial results for 2018. The Company reports a 38% increase in net revenues ...
April 29, 2019
Nicox to Present at Upcoming Pharmaceutical Industry and Financial Events
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that it will be presenting at the following pharmaceutical industry and financial events ...
April 29, 2019
Pluristem Completes Interim Enrollment in Pivotal CLI Study, Targeting Potential Conditional Marketing Approval in Europe
HAIFA, Israel, April 29, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today ...
April 29, 2019
miRagen Therapeutics Announces New Data Supporting the Potential Use of Remlarsen to Prevent Corneal Fibrosis at the 2019 ARVO Meeting
BOULDER, Colo., April 29, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, ...
April 29, 2019
Orchard Therapeutics Announces Clinical Proof-of-Concept Data for Gene Therapy OTL-300 Demonstrating Efficacy in Transfusion-Dependent Beta-Thalassemia
BOSTON and LONDON, April 29, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with ...
April 29, 2019
Orchard Therapeutics Announces Clinical Proof-of-Concept Data for Gene Therapy OTL-300 Demonstrating Efficacy in Transfusion-Dependent Beta-Thalassemia
BOSTON and LONDON, April 29, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with ...
April 29, 2019
Spring Bank Pharmaceuticals Reports First Quarter 2019 Financial and Operational Results and Provides Corporate Update
HOPKINTON, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
April 29, 2019
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
REDWOOD CITY, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
April 29, 2019
Foamix to Present Late Breaking Data at the 77th Annual Meeting of the Society for Investigative Dermatology
REHOVOT, Israel and BRIDGEWATER, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company ...
April 29, 2019
EDAP TMS SA : EDAP to Showcase Suite of Therapeutic Ultrasound Products During the American Urology Association Annual Meeting
LYON, France, April 29, 2019 -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, announced today that it will demonstrate the capabilities of its range of minimally-invasive ...
April 29, 2019
Catalyst Biosciences & Mosaic Biosciences Present Preclinical Data on Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., April 29, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), and Mosaic Biosciences today announced the presentation of ...
April 10, 2019
VALNEVA to Present on Lyme and Chikungunya Vaccine Candidates at the 19th World Vaccine Congress
Saint Herblain (France), April 9, 2019 - Valneva SE ("Valneva" or "the Company"), a biotech company developing and commercializing vaccines for infectious diseases with major ...
April 10, 2019
OSE Immunotherapeutics Announces Issuance of Canadian Patent and Notice of Allowance of U.S. Patent Protecting CD28-Antagonist Immunotherapy FR104
NANTES, France, April 09, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announces that it has strengthened its intellectual property rights for ...
April 10, 2019
Veyonda® Chemotherapy Enhancement Program to be Expanded
SYDNEY, Australia, April 10, 2019 (GLOBE NEWSWIRE) -- Noxopharm Ltd (ASX:NOX) (Noxopharm or the ‘Company’) provides an update on the progress of its Veyonda® chemotherapy ...
April 10, 2019
Sorrento Therapeutics Announces Discovery of a Potential Non-Dopaminergic Approach to Controlling Parkinson’s Motor Symptoms With Resiniferatoxin (RTX) Intrathecal Administration
SAN DIEGO, April 10, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announces positive and better than initially hoped for top line results ...
April 10, 2019
Outlook Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
CRANBURY, N.J., April 10, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (OTLK) (the “Company”) announced today the pricing of an underwritten public offering of 10,340,000 ...
April 10, 2019
PolarityTE Announces Pricing of Public Offering of Common Stock
SALT LAKE CITY, April 10, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a commercial-stage biotechnology company focused on transforming the lives of patients by discovering, designing and ...
April 10, 2019
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting
Basel, Switzerland, April 10, 2019 – Basilea Pharmaceutica Ltd. (BSLN.SW) reported that shareholders approved all proposals of the Board of Directors at today’s Annual General ...
April 8, 2019
aTyr Pharma to Present Poster at the American Thoracic Society 2019 International Conference
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based ...
Page 12 of 150